David Copeland, 55, of Tallahassee, Fla., James Moss, 60, of Huntsville, Ala., and Michael Gordon, 60, of Fort Myers, Fla., were sentenced for their roles in the scheme following guilty pleas, according to a Nov. 15 news release from the Justice Department.
Mr. Moss and Mr. Copeland were part owners of a Florida based pharmacy and Mr. Gordon was a lead sales representative. The trio engaged in a practice to develop the most expensive combination of drugs to maximize reimbursements from Tricare. From 2012 through 2015, the pharmacy billed Tricare more than $54 million for its compounded pharmaceuticals.
Additionally, they targeted physicians who treated Tricare beneficiaries and offered bribes and kickbacks to encourage referrals. Mr. Moss paid his co-conspirators millions in kickbacks based on percentages of the TriCare reimbursements, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
